Comparison of the efficacy and safety of Shanhuang Jiangzhi tablets and atorvastatin in the treatment of patients with hyperlipidaemia
CONCLUSIONS: Shanhuang Jiangzhi tablets have a higher hypotriglyceridaemic performance than atorvastatin and an equivalent ability to lower TC and LDL-C. In addition, Shanhuang Jiangzhi tablets are a low-risk option for lowering blood lipids.PMID:38098069 | PMC:PMC10722779 | DOI:10.1186/s41043-023-00482-3
Source: Journal of Health, Population, and Nutrition - Category: International Medicine & Public Health Authors: GuoTong Sun XiuWen Liang Source Type: research
More News: Atorvastatin Calcium | Cholesterol | International Medicine & Public Health | Lipitor | Nutrition | Statin Therapy | Statistics | Study | Zivast